Bladder Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Nov 21, 2018
- Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.
Meric-Bernstam Funda et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov - Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
Xu Yanjie et al. Urologic oncology 2018 Nov - Genomic classification and risk stratification of bladder cancer.
Fantini Damiano et al. World journal of urology 2018 Nov - Circulating miRNA Panels for Specific and Early Detection in Bladder Cancer.
Usuba Wataru et al. Cancer science 2018 Nov - Novel biomarkers in bladder cancer.
Cheng Michael L et al. Urologic oncology 2018 36(3) 115-119 - Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behaviour of bladder cancer.
Leão Ricardo et al. International journal of cancer 2018 Oct - Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
Yang Lingjian et al. EBioMedicine 2018 May 31182-189 - Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.
Ansari Adnan Ahmad et al. BMC medical genomics 2018 Oct 11(1) 88 - Clinical performance and utility of a NNMT-based urine test for bladder cancer.
Pozzi Valentina et al. The International journal of biological markers 2018 Jan 33(1) 94-101 - Precision medicine and bladder cancer heterogeneity.
Ma Guofeng et al. Bulletin du cancer 2018 Sep
No hay comentarios:
Publicar un comentario